Clik here to view.
Big Data, Big Biology, and the ‘Tipping Point’ in Quantified Health
Bruce V. Bigelow Two of the biggest trends in technology innovation are converging—and as they …
View ArticleClik here to view.
Biodesix’s VeriStrat Test for Cancer Treatment Passes Phase 3 Trial
Michael Davidson Biodesix, a Boulder, CO-based company that develops molecular diagnostic tests, said today that it has passed a key clinical trial that shows its VeriStrat test can give …
View ArticleClik here to view.
SomaLogic Partners with Agilent to Distribute Proteomic Technology
Michael Davidson SomaLogic and Agilent Technologies announced Monday they have formed a partnership to install SomaLogic’s protein biomarker discovery platform at research centers around the country....
View ArticleClik here to view.
Applied Proteomics Snags $28M to Look for Disease Markers in Blood
Bruce V. Bigelow San Diego’s Applied Proteomics, founded in 2007 to automate the process of accurately measuring all the protein fragments in a drop of blood, has raised $28 million …
View ArticleClik here to view.
SomaLogic Names New CEO; Founder Larry Gold to Stay on as Chairman
Michael Davidson After 13 years at the helm of SomaLogic, a Boulder, CO-based startup developing diagnostic tests that use protein biomarkers to identify maladies, Larry Gold is stepping down …
View ArticleBacked By a Billionaire, Berg Pharma Aims to Speed Drugmaking
Ben Fidler Even in the brazen world of biotech, Berg Pharma stands out for its grand ambitions. Co-founder Carl Berg, the Silicon Valley real estate billionaire, says his namesake Framingham, …
View ArticleBIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery
Sharon C. Presnell Editor’s Note: Sharon Presnell discussed the use of bioprinting and 3D tissue to improve predictability in preclinical drug discovery this week at the BIO 2014 convention in …
View Article